-
公开(公告)号:ES2197062T3
公开(公告)日:2004-01-01
申请号:ES00610050
申请日:2000-05-22
Applicant: SERVIER LAB
Inventor: DEPREUX PATRICK , YOUS SAID , CHEVE GWENAEL , GUILLAUMET GERALD , VIAUD MARIE-CLAUDE , LARRAYA CARLOS
IPC: C07D319/20 , A61K31/24 , A61K31/34 , A61K31/343 , A61K31/352 , A61K31/357 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/403 , A61K31/404 , A61K31/4355 , A61K31/44 , A61P1/14 , A61P3/00 , A61P9/00 , A61P9/02 , A61P25/00 , A61P25/20 , A61P25/24 , A61P25/28 , A61P43/00 , C07C233/22 , C07D209/16 , C07D307/79 , C07D307/80 , C07D307/81 , C07D311/58 , C07D333/58 , C07D333/60 , C07D333/66 , C07D339/08 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/12 , C07D409/12 , C07D471/04
Abstract: The invention relates to compound of formula (I):wherein:A represents a grouping NR1C(Q)R2, C(Q)NR2R3 or NR1C(Q)NR2R3,B represents a grouping NR1C(Q)R2, NR1C(Q)NR2R3, C(Q)NR2R3, C(Q)OR1, NR1C(Q)OR2 or NR2R3,G1 and G3 represent an optionally substituted alkylene chain,Cy and Cy', which are different, represent a ring structureorG2 represents a chainand medicinal products containing the same are useful in treating or in preventing melatoninergic disorders.
-
公开(公告)号:AT237610T
公开(公告)日:2003-05-15
申请号:AT00610050
申请日:2000-05-22
Applicant: SERVIER LAB
Inventor: DEPREUX PATRICK , YOUS SAID , CHEVE GWENAEL , GUILLAUMET GERALD , VIAUD MARIE-CLAUDE , LARRAYA CARLOS , BENNEJEAN CAROLINE , DELAGRANGE PHILIPPE , REGARD PIERRE , DESCAMPS-FRANCOIS CAROLE
IPC: C07D319/20 , A61K31/24 , A61K31/34 , A61K31/343 , A61K31/352 , A61K31/357 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/403 , A61K31/404 , A61K31/4355 , A61K31/44 , A61P1/14 , A61P3/00 , A61P9/00 , A61P9/02 , A61P25/00 , A61P25/20 , A61P25/24 , A61P25/28 , A61P43/00 , C07C233/22 , C07D209/16 , C07D307/79 , C07D307/80 , C07D307/81 , C07D311/58 , C07D333/58 , C07D333/60 , C07D333/66 , C07D339/08 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/12 , C07D409/12 , C07D471/04
Abstract: The invention relates to compound of formula (I):wherein:A represents a grouping NR1C(Q)R2, C(Q)NR2R3 or NR1C(Q)NR2R3,B represents a grouping NR1C(Q)R2, NR1C(Q)NR2R3, C(Q)NR2R3, C(Q)OR1, NR1C(Q)OR2 or NR2R3,G1 and G3 represent an optionally substituted alkylene chain,Cy and Cy', which are different, represent a ring structureorG2 represents a chainand medicinal products containing the same are useful in treating or in preventing melatoninergic disorders.
-
公开(公告)号:HK1030937A1
公开(公告)日:2001-05-25
申请号:HK01101746
申请日:2001-03-12
Applicant: SERVIER LAB
Inventor: DEPREUX PATRICK , YOUS SAID , CHEVE GWENAEL , GUILLAUMET GERALD , VIAUD MARIE-CLAUDE , LARRAYA CARLOS , BENNEJEAN CAROLINE , DELAGRANGE PHILIPPE , RENARD PIERRE , DESCAMPS-FRANCOIS CAROLE
IPC: C07D319/20 , A61K31/24 , A61K31/34 , A61K31/343 , A61K31/352 , A61K31/357 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/403 , A61K31/404 , A61K31/4355 , A61K31/44 , A61P1/14 , A61P3/00 , A61P9/00 , A61P9/02 , A61P25/00 , A61P25/20 , A61P25/24 , A61P25/28 , A61P43/00 , C07C233/22 , C07D209/16 , C07D307/79 , C07D307/80 , C07D307/81 , C07D311/58 , C07D333/58 , C07D333/60 , C07D333/66 , C07D339/08 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/12 , C07D409/12 , C07D471/04 , C07D , A61K , A61P
Abstract: The invention relates to compound of formula (I):wherein:A represents a grouping NR1C(Q)R2, C(Q)NR2R3 or NR1C(Q)NR2R3,B represents a grouping NR1C(Q)R2, NR1C(Q)NR2R3, C(Q)NR2R3, C(Q)OR1, NR1C(Q)OR2 or NR2R3,G1 and G3 represent an optionally substituted alkylene chain,Cy and Cy', which are different, represent a ring structureorG2 represents a chainand medicinal products containing the same are useful in treating or in preventing melatoninergic disorders.
-
公开(公告)号:PT1057826E
公开(公告)日:2003-08-29
申请号:PT00610050
申请日:2000-05-22
Applicant: SERVIER LAB
Inventor: GUILLAUMET GERALD , DEPREUX PATRICK , DELAGRANGE PHILIPPE , VIAUD MARIE-CLAUDE , BENNEJEAN CAROLINE , YOUS SAID , CHEVE GWENAEL , LARRAYA CARLOS , REGARD PIERRE , DESCAMPS-FRANCOIS CAROLE
IPC: C07D319/20 , A61K31/24 , A61K31/34 , A61K31/343 , A61K31/352 , A61K31/357 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/403 , A61K31/404 , A61K31/4355 , A61K31/44 , A61P1/14 , A61P3/00 , A61P9/00 , A61P9/02 , A61P25/00 , A61P25/20 , A61P25/24 , A61P25/28 , A61P43/00 , C07C233/22 , C07D209/16 , C07D307/79 , C07D307/80 , C07D307/81 , C07D311/58 , C07D333/58 , C07D333/60 , C07D333/66 , C07D339/08 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/12 , C07D409/12 , C07D471/04
Abstract: The invention relates to compound of formula (I):wherein:A represents a grouping NR1C(Q)R2, C(Q)NR2R3 or NR1C(Q)NR2R3,B represents a grouping NR1C(Q)R2, NR1C(Q)NR2R3, C(Q)NR2R3, C(Q)OR1, NR1C(Q)OR2 or NR2R3,G1 and G3 represent an optionally substituted alkylene chain,Cy and Cy', which are different, represent a ring structureorG2 represents a chainand medicinal products containing the same are useful in treating or in preventing melatoninergic disorders.
-
公开(公告)号:DE60002126D1
公开(公告)日:2003-05-22
申请号:DE60002126
申请日:2000-05-22
Applicant: SERVIER LAB
Inventor: DEPREUX PATRICK , YOUS SAID , CHEVE GWENAEL , GUILLAUMET GERALD , VIAUD MARIE-CLAUDE , LARRAYA CARLOS , BENNEJEAN CAROLINE , DELAGRANGE PHILIPPE , REGARD PIERRE , DESCAMPS-FRANCOIS CAROLE
IPC: C07D319/20 , A61K31/24 , A61K31/34 , A61K31/343 , A61K31/352 , A61K31/357 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/403 , A61K31/404 , A61K31/4355 , A61K31/44 , A61P1/14 , A61P3/00 , A61P9/00 , A61P9/02 , A61P25/00 , A61P25/20 , A61P25/24 , A61P25/28 , A61P43/00 , C07C233/22 , C07D209/16 , C07D307/79 , C07D307/80 , C07D307/81 , C07D311/58 , C07D333/58 , C07D333/60 , C07D333/66 , C07D339/08 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/12 , C07D409/12 , C07D471/04
Abstract: The invention relates to compound of formula (I):wherein:A represents a grouping NR1C(Q)R2, C(Q)NR2R3 or NR1C(Q)NR2R3,B represents a grouping NR1C(Q)R2, NR1C(Q)NR2R3, C(Q)NR2R3, C(Q)OR1, NR1C(Q)OR2 or NR2R3,G1 and G3 represent an optionally substituted alkylene chain,Cy and Cy', which are different, represent a ring structureorG2 represents a chainand medicinal products containing the same are useful in treating or in preventing melatoninergic disorders.
-
公开(公告)号:EA003391B1
公开(公告)日:2003-04-24
申请号:EA200000431
申请日:2000-05-18
Applicant: SERVIER LAB
Inventor: DEPREUX PATRICK , YOUS SAID , CHEVE GWENAEL , GUILLAUMET GERARD , VIAUD MARIE-CLAUDE , LARRAYA CARLOS , BENNEJEAN CAROLINE , DELAGRANGE PHILIPPE , RENARD PIERRE , DESCAMPS-FRANCOIS CAROLE
IPC: C07D319/20 , A61K31/24 , A61K31/34 , A61K31/343 , A61K31/352 , A61K31/357 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/403 , A61K31/404 , A61K31/4355 , A61K31/44 , A61P1/14 , A61P3/00 , A61P9/00 , A61P9/02 , A61P25/00 , A61P25/20 , A61P25/24 , A61P25/28 , A61P43/00 , C07C233/22 , C07D209/16 , C07D307/79 , C07D307/80 , C07D307/81 , C07D311/58 , C07D333/58 , C07D333/60 , C07D333/66 , C07D339/08 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/12 , C07D409/12 , C07D471/04 , C07D409/10 , C07D405/10 , C07D209/14 , C07C233/25 , A61K31/437 , A61K31/165
Abstract: Изобретениеотноситсяк соединениямформулы (I)A-G-Cy-G-Cy'-G-B (I)гдеА представляетгруппу NRC(Q)R, C(Q)NRRили NRC(Q)NRR;Впредставляетгруппу NRC(Q)R, NRC(Q)NRR, C(Q)NRR, C(Q)OR, NRC(Q)ORили NRR;Gи Gпредставляютнеобязательнозамещеннуюалкиленовуюцепь;Суи Су', которыеявляютсяразличными, представляюткольцевуюструктуруилиGпредставляетцепьЛекарственныепрепараты
-
公开(公告)号:SI1057826T1
公开(公告)日:2003-08-31
申请号:SI200030081
申请日:2000-05-22
Applicant: SERVIER LAB
Inventor: DEPREUX PATRICK , YOUS SAID , CHEVE GWENAEL , GUILLAUMET GERALD , VIAUD MARIE-CLAUDE , LARRAYA CARLOS , BENNEJEAN CAROLINE , DELAGRANGE PHILIPPE , REGARD PIERRE , DESCAMPS-FRANCOIS CAROLE
IPC: C07D319/20 , A61K31/24 , A61K31/34 , A61K31/343 , A61K31/352 , A61K31/357 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/403 , A61K31/404 , A61K31/4355 , A61K31/44 , A61P1/14 , A61P3/00 , A61P9/00 , A61P9/02 , A61P25/00 , A61P25/20 , A61P25/24 , A61P25/28 , A61P43/00 , C07C233/22 , C07D209/16 , C07D307/79 , C07D307/80 , C07D307/81 , C07D311/58 , C07D333/58 , C07D333/60 , C07D333/66 , C07D339/08 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/12 , C07D409/12 , C07D471/04
Abstract: The invention relates to compound of formula (I):wherein:A represents a grouping NR1C(Q)R2, C(Q)NR2R3 or NR1C(Q)NR2R3,B represents a grouping NR1C(Q)R2, NR1C(Q)NR2R3, C(Q)NR2R3, C(Q)OR1, NR1C(Q)OR2 or NR2R3,G1 and G3 represent an optionally substituted alkylene chain,Cy and Cy', which are different, represent a ring structureorG2 represents a chainand medicinal products containing the same are useful in treating or in preventing melatoninergic disorders.
-
公开(公告)号:EA200000431A3
公开(公告)日:2001-02-26
申请号:EA200000431
申请日:2000-05-18
Applicant: SERVIER LAB
Inventor: DEPREUX PATRICK , YOUS SAID , CHEVE GWENAEL , GUILLAUMET GERARD , VIAUD MARIE-CLAUDE , LARRAYA CARLOS , BENNEJEAN CAROLINE , DELAGRANGE PHILIPPE , RENARD PIERRE , DESCAMPS-FRANCOIS CAROLE
IPC: C07D319/20 , A61K31/24 , A61K31/34 , A61K31/343 , A61K31/352 , A61K31/357 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/403 , A61K31/404 , A61K31/4355 , A61K31/44 , A61P1/14 , A61P3/00 , A61P9/00 , A61P9/02 , A61P25/00 , A61P25/20 , A61P25/24 , A61P25/28 , A61P43/00 , C07C233/22 , C07D209/16 , C07D307/79 , C07D307/80 , C07D307/81 , C07D311/58 , C07D333/58 , C07D333/60 , C07D333/66 , C07D339/08 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/12 , C07D409/12 , C07D471/04
Abstract: (57) Изобретениеотноситсяк соединениямформулы (I)A-G-Cy-G-Cy'-G-B (I)гдеА представляетгруппу NRC(Q)R, C(Q)NRRили NRC(Q)NRR;Впредставляетгруппу NRC(Q)R, NRC(Q)NRR, C(Q)NRR, C(Q)OR, NRC(Q)ORили NRR;Gи Gпредставляютнеобязательнозамещеннуюалкиленовуюцепь;Суи Су', которыеявляютсяразличными, представляюткольцевуюструктуруилиGпредставляетцепьЛекарственныепрепараты.
-
公开(公告)号:DE60002126T2
公开(公告)日:2004-03-18
申请号:DE60002126
申请日:2000-05-22
Applicant: SERVIER LAB
Inventor: DEPREUX PATRICK , YOUS SAID , CHEVE GWENAEL , GUILLAUMET GERALD , VIAUD MARIE-CLAUDE , LARRAYA CARLOS , BENNEJEAN CAROLINE , DELAGRANGE PHILIPPE , REGARD PIERRE , DESCAMPS-FRANCOIS CAROLE
IPC: C07D319/20 , A61K31/24 , A61K31/34 , A61K31/343 , A61K31/352 , A61K31/357 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/403 , A61K31/404 , A61K31/4355 , A61K31/44 , A61P1/14 , A61P3/00 , A61P9/00 , A61P9/02 , A61P25/00 , A61P25/20 , A61P25/24 , A61P25/28 , A61P43/00 , C07C233/22 , C07D209/16 , C07D307/79 , C07D307/80 , C07D307/81 , C07D311/58 , C07D333/58 , C07D333/60 , C07D333/66 , C07D339/08 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/12 , C07D409/12 , C07D471/04
Abstract: The invention relates to compound of formula (I):wherein:A represents a grouping NR1C(Q)R2, C(Q)NR2R3 or NR1C(Q)NR2R3,B represents a grouping NR1C(Q)R2, NR1C(Q)NR2R3, C(Q)NR2R3, C(Q)OR1, NR1C(Q)OR2 or NR2R3,G1 and G3 represent an optionally substituted alkylene chain,Cy and Cy', which are different, represent a ring structureorG2 represents a chainand medicinal products containing the same are useful in treating or in preventing melatoninergic disorders.
-
10.
公开(公告)号:EA200000431A2
公开(公告)日:2000-12-25
申请号:EA200000431
申请日:2000-05-18
Applicant: SERVIER LAB
Inventor: DEPREUX PATRICK , YOUS SAID , CHEVE GWENAEL , GUILLAUMET GERARD , VIAUD MARIE-CLAUDE , LARRAYA CARLOS , BENNEJEAN CAROLINE , DELAGRANGE PHILIPPE , RENARD PIERRE , DESCAMPS-FRANCOIS CAROLE
IPC: C07D319/20 , A61K31/24 , A61K31/34 , A61K31/343 , A61K31/352 , A61K31/357 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/403 , A61K31/404 , A61K31/4355 , A61K31/44 , A61P1/14 , A61P3/00 , A61P9/00 , A61P9/02 , A61P25/00 , A61P25/20 , A61P25/24 , A61P25/28 , A61P43/00 , C07C233/22 , C07D209/16 , C07D307/79 , C07D307/80 , C07D307/81 , C07D311/58 , C07D333/58 , C07D333/60 , C07D333/66 , C07D339/08 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/12 , C07D409/12 , C07D471/04
Abstract: Изобретениеотноситсяк соединениямформулы (I)A-G-Cy-G-Cy'-G-B (I)где A представляетгруппу NRC(Q)R, C(Q)NRRили NRC(Q)NRR;B представляетгруппу NRC(Q)R, NRC(Q)NRR, C(Q)NRR, C(Q)OR, NRC(Q)ORили NRR;Gи Gпредставляютнеобязательнозамещеннуюалкиленовуюцепь;Cy и Cy', которыеявляютсяразличными, представляюткольцевуюструктуруилиGпредставляетцепьЛекарственныепрепараты.
-
-
-
-
-
-
-
-
-